EFFECTIVENESS OF BEVACIZUMAB IN PLATINUM-RESISTANT RECURRENT EPITHELIAL OVARIAN CANCER

被引：0
|
作者：
Pinto, R. [1 ]
Monteiro, S. [1 ]
Lima, B. [2 ]
Lopes, A. R. [1 ]
Abreu, M. [1 ]
Ferreira, M. [1 ]
Sousa, S. [1 ]
Redondo, P. [1 ]
Pereira, D. [1 ]
Savva-Bordalo, J. [1 ]
机构：
[1] Portuguese Oncol Inst Porto, Porto, Portugal
[2] Hosp Senhora Oliveira, Creixomil, Portugal
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2021年 / 31卷
关键词：
D O I：
10.1136/ijgc-2021-ESGO.465
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
759
引用
收藏
页码：A271 / A271
页数：1
相关论文
共 50 条
  • [1] Platinum-resistant recurrent ovarian cancer with long survival on bevacizumab and gemcitabine
    Komiyama, Shinichi
    Kugimiya, Tsuyoki
    Takeya, Chiaki
    Takahashi, Rena
    Kubushiro, Kaneyuki
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2018, 44 (07) : 1330 - 1334
  • [2] BEVACIZUMAB IN THE TREATMENT FOR PLATINUM-RESISTANT EPITHELIAL OVARIAN CARCINOMA
    Cuellar Angeles, Flores
    Yanez Elena, Sanchez
    Contreras Josefina, Gonzalez
    [J]. ATENCION FARMACEUTICA, 2011, 13 (01): : 8 - +
  • [3] Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
    Ball G.
    Xie F.
    Tarride J.-E.
    [J]. PharmacoEconomics - Open, 2018, 2 (1) : 19 - 29
  • [4] A FEASIBILITY STUDY OF GEMCITABINE AND BEVACIZUMAB IN WOMEN WITH PLATINUM-RESISTANT RECURRENT OVARIAN CANCER
    Nagao, S.
    Kogiku, A.
    Ota, M.
    Yamamoto, K.
    Narita, M.
    Shimada, K.
    Nagazawa, H.
    Shibutani, T.
    Yamamoto, K.
    Jimi, T.
    Yano, H.
    Kitai, M.
    Shiozaki, T.
    Matsuoka, K.
    Yamaguchi, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A501 - A501
  • [5] Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis
    Kazuki Takasaki
    Morikazu Miyamoto
    Masashi Takano
    Hiroaki Soyama
    Tadashi Aoyama
    Hiroko Matsuura
    Kento Kato
    Takahiro Sakamoto
    Mika Kuwahara
    Hideki Iwahashi
    Hiroki Ishibashi
    Tomoyuki Yoshikawa
    Kenichi Furuya
    [J]. Cancer Chemotherapy and Pharmacology, 2018, 81 : 809 - 814
  • [6] Vinorelbine for the treatment of recurrent progressive platinum-resistant epithelial ovarian cancer
    Berry, E.
    Hoekstra, A. V.
    Singh, D. K.
    Buttin, B. M.
    Schink, J. C.
    Lurain, J. R.
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 365 - 365
  • [7] Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis
    Takasaki, Kazuki
    Miyamoto, Morikazu
    Takano, Masashi
    Soyama, Hiroaki
    Aoyama, Tadashi
    Matsuura, Hiroko
    Kato, Kento
    Sakamoto, Takahiro
    Kuwahara, Mika
    Iwahashi, Hideki
    Ishibashi, Hiroki
    Yoshikawa, Tomoyuki
    Furuya, Kenichi
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (05) : 809 - 814
  • [8] Surgery in platinum-resistant recurrent epithelial ovarian carcinoma
    Zhao, Ling-Qin
    Gao, Wen
    Zhang, Ping
    Zhang, Ying-Li
    Fang, Chen-Yan
    Shou, Hua-Feng
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (12) : 3739 - 3753
  • [9] Surgery in platinum-resistant recurrent epithelial ovarian carcinoma
    Ling-Qin Zhao
    Wen Gao
    Ping Zhang
    Ying-Li Zhang
    Chen-Yan Fang
    Hua-Feng Shou
    [J]. World Journal of Clinical Cases, 2022, 10 (12) : 3739 - 3753
  • [10] Platinum-gemcitabine-bevacizumab (PGA) for platinum-resistant/refractory recurrent ovarian cancer.
    Niu, Jiaxin
    Kundranda, Madappa N.
    Weiss, Glen J.
    Farley, John H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345